BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J. Hepatitis C viral infection in liver transplant recipients. Hepatology. 1992;16:865-876. [PMID: 1383115 DOI: 10.1002/hep.1840160403] [Cited by in Crossref: 175] [Cited by in F6Publishing: 156] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Alsatie M, Chalasani N, Kwo PY. Management of hepatitis C infection after liver transplantation. Drugs 2007;67:871-85. [PMID: 17428105 DOI: 10.2165/00003495-200767060-00004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
2 Greenson JK, Svoboda-Newman SM, Merion RM, Frank TS. Histologic progression of recurrent hepatitis C in liver transplant allografts. Am J Surg Pathol 1996;20:731-8. [PMID: 8651353 DOI: 10.1097/00000478-199606000-00011] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 2.0] [Reference Citation Analysis]
3 Stanca CM, Fiel MI, Kontorinis N, Agarwal K, Emre S, Schiano TD. Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin. Transplantation. 2007;84:180-186. [PMID: 17667809 DOI: 10.1097/01.tp.0000269609.08495.45] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
4 Portmann B, Koukoulis G. Pathology of the Liver Allograft. In: Berry CL, editor. Transplantation Pathology. Berlin: Springer Berlin Heidelberg; 1999. pp. 61-105. [DOI: 10.1007/978-3-642-59877-7_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
5 Demetris AJ; Banff Working Group. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006;44:489-501. [DOI: 10.1002/hep.21280] [Cited by in Crossref: 256] [Cited by in F6Publishing: 194] [Article Influence: 16.0] [Reference Citation Analysis]
6 Dusheiko G. Summary: antiviral treatment of hepatitis C virus. Antiviral Research 1996;29:77-82. [DOI: 10.1016/0166-3542(95)00923-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Kojima H, Kaita KD, Hawkins K, Uhanova J, Minuk GY. Use of fluoroquinolones in patients with chronic hepatitis C virus-induced liver failure. Antimicrob Agents Chemother 2002;46:3280-2. [PMID: 12234860 DOI: 10.1128/AAC.46.10.3280-3282.2002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
8 Perumpail RB, Hahambis TA, Aggarwal A, Younossi ZM, Ahmed A. Treatment strategies for chronic hepatitis C prior to and following liver transplantation. World J Hepatol 2016; 8(1): 69-73 [PMID: 26783422 DOI: 10.4254/wjh.v8.i1.69] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
9 Dickson RC, Caldwell SH, Ishitani MB, Lau JY, Driscoll CJ, Stevenson WC, McCullough CS, Pruett TL. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation. 1996;61:701-705. [PMID: 8607170 DOI: 10.1097/00007890-199603150-00005] [Cited by in Crossref: 135] [Cited by in F6Publishing: 112] [Article Influence: 5.2] [Reference Citation Analysis]
10 Pastore M, Willems M, Cornu C, Buts JP, Reding R, de Ville de Goyet J, Rahier J, Otte JB, Yap SH, Sokal EM. Role of hepatitis C virus in chronic liver disease occurring after orthotopic liver transplantation. Archives of Disease in Childhood 1995;72:403-7. [DOI: 10.1136/adc.72.5.403] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
11 Zekry A, Bishop GA, Bowen DG, Gleeson MM, Guney S, Painter DM, McCaughan GW. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury. Liver Transpl. 2002;8:292-301. [PMID: 11910576 DOI: 10.1053/jlts.2002.31655] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 2.9] [Reference Citation Analysis]
12 Gao Z. Seeking Beyond Rejection: An Update on the Differential Diagnosis and a Practical Approach to Liver Allograft Biopsy Interpretation. Advances in Anatomic Pathology 2009;16:97-117. [DOI: 10.1097/pap.0b013e31819946aa] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Guerrero RB, Batts KP, Burgart LJ, Barrett SL, Germer JJ, Poterucha JJ, Wiesner RH, Charlton MR, Persing DH. Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study. Mod Pathol. 2000;13:229-237. [PMID: 10757333 DOI: 10.1038/modpathol.3880043] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 2.2] [Reference Citation Analysis]
14 Tibbs CJ, Williams R. Liver transplantation for acute and chronic viral hepatitis. J Viral Hepat 1995;2:65-72. [PMID: 7493299 DOI: 10.1111/j.1365-2893.1995.tb00008.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
15 Charco R, Vargas V, Allende H, Edo A, Balsells J, Murio E, Lázaro JL, Bilbao I, Margarit C. Is hepatitis C virus recurrence a risk factor for chronic liver allograft rejection? Transpl Int 1996;9 Suppl 1:S195-7. [PMID: 8959825 DOI: 10.1007/978-3-662-00818-8_49] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Caccamo L, Colledan M, Gridelli B, Rossi G, Doglia M, Gatti S, Ghidoni P, Lucianetti A, Lunghi G, Maggi U. Hepatitis C virus infection in liver allograft recipients. Arch Virol Suppl 1993;8:291-304. [PMID: 7505145 DOI: 10.1007/978-3-7091-9312-9_30] [Reference Citation Analysis]
17 Sadamori H, Yagi T, Iwagaki H, Matsuda H, Shinoura S, Umeda Y, Ohara N, Yanai H, Ogino T, Tanaka N. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation. J Gastroenterol Hepatol. 2009;24:574-580. [PMID: 19368635 DOI: 10.1111/j.1440-1746.2008.05638.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
18 Vargas HE, Laskus T, Wang L, Radkowski M, Poutous A, Lee R, Demetris JA, Gayowski T, Marino IR, Singh N, Dodson F, Casavilla A, Fung JJ, Rakela J. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl 1998;4:22-7. [DOI: 10.1002/lt.500040103] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 3.3] [Reference Citation Analysis]
19 Crosbie OM, Alexander GJ. Liver transplantation for hepatitis C virus related cirrhosis. Best Practice & Research Clinical Gastroenterology 2000;14:307-25. [DOI: 10.1053/bega.1999.0078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
20 Prince MI, Hudson M. Liver transplantation for chronic liver disease: advances and controversies in an era of organ shortages. Postgrad Med J 2002;78:135-41. [PMID: 11884694 DOI: 10.1136/pmj.78.917.135] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
21 Berenguer M, Wright TL. TREATMENT STRATEGIES FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION. Clinics in Liver Disease 1999;3:883-99. [DOI: 10.1016/s1089-3261(05)70245-2] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
22 Taga SA, Washington MK, Terrault N, Wright TL, Somberg KA, Ferrell LD. Cholestatic hepatitis C in liver allografts. Liver Transpl 1998;4:304-10. [DOI: 10.1002/lt.500040401] [Cited by in Crossref: 69] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
23 Böker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, Oldhaver K, Bode U, Pichlmayr R, Manns MP. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology. 1997;25:203-210. [PMID: 8985291 DOI: 10.1002/hep.510250137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 22] [Article Influence: 0.2] [Reference Citation Analysis]
24 Berenguer M, López-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol. 2001;35:666-678. [PMID: 11690716 DOI: 10.1016/s0168-8278(01)00179-9] [Cited by in Crossref: 222] [Cited by in F6Publishing: 45] [Article Influence: 11.1] [Reference Citation Analysis]
25 Miller K, McArdle S, Gale MJ Jr, Geller DA, Tenoever B, Hiscott J, Gretch DR, Polyak SJ. Effects of the hepatitis C virus core protein on innate cellular defense pathways. J Interferon Cytokine Res 2004;24:391-402. [PMID: 15296650 DOI: 10.1089/1079990041535647] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
26 Vargas V, Krawczynski K, Castells L, Martinez N, Esteban J, Allende H, Esteban R, Guardia J. Recurrent hepatitis C virus infection after liver transplantation: immunohistochemical assessment of the viral antigen. Liver Transpl Surg. 1998;4:320-327. [PMID: 9649647 DOI: 10.1002/lt.500040407] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
27 Demetris AJ. Evolution of hepatitis C virus in liver allografts. Liver Transpl. 2009;15 Suppl 2:S35-S41. [PMID: 19876940 DOI: 10.1002/lt.21890] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
28 Rosen HR, Martin P. Hepatitis C infection in patients undergoing liver retransplantation. Transplantation 1998;66:1612-6. [PMID: 9884247 DOI: 10.1097/00007890-199812270-00007] [Cited by in Crossref: 102] [Cited by in F6Publishing: 90] [Article Influence: 4.4] [Reference Citation Analysis]
29 Smallwood GA, Devine R, Fasola C, Stieber AC, Heffron TG. Does interferon use prior to liver transplant influence hepatitis C outcomes following transplantation? Transplantation 2008;86:1795-8. [PMID: 19104424 DOI: 10.1097/TP.0b013e3181914188] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
30 Davis CL, Gretch DR, Perkins JD, Harris AW, Wener MH, Alpers CE, Lesniewski R, Lee W, dela Rosa C, Johnson RJ. Hepatitis C--associated glomerular disease in liver transplant recipients. Liver Transpl Surg 1995;1:166-75. [PMID: 9346560 DOI: 10.1002/lt.500010306] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
31 Wright TL. LIVER TRANSPLANTATION FOR CHRONIC HEPATITIS C VIRAL INFECTION. Gastroenterology Clinics of North America 1993;22:231-42. [DOI: 10.1016/s0889-8553(21)00064-9] [Cited by in Crossref: 7] [Article Influence: 0.2] [Reference Citation Analysis]
32 Fragulidis GP, Cirocco RE, Weppler D, Berho M, Gillian G, Markou M, Viciana A, Esquenazi V, Nery JR, Miller J, Reddy KR, Tzakis AG. In situ enzymatic oligonucleotide amplification of hepatitis C virus-RNA in liver biopsy specimens (reverse transcriptase in situ polymerase chain reaction) after orthotopic liver transplantation for hepatitis C-related liver disease. Transplantation 1998;66:1472-6. [PMID: 9869088 DOI: 10.1097/00007890-199812150-00010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
33 Fukumoto T, Berg T, Ku Y, Bechstein W, Hopf U, Neuhaus P. Kinetics of hepatitis C viremia after orthotopic liver transplantation. Transplantation Proceedings 1997;29:511-3. [DOI: 10.1016/s0041-1345(96)00242-4] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
34 Pham YH, Rosenthal P. Chronic Hepatitis C Infection in Children. Advances in Pediatrics 2016;63:173-94. [DOI: 10.1016/j.yapd.2016.04.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
35 Guerrero RB, Batts KP, Germer JJ, Perez RG, Wiesner RH, Persing DH. Reverse transcriptase-polymerase chain reaction fails to detect peripheral-blood hepatitis C RNA in formalin-fixed liver tissue. Liver Transpl 1998;4:455-60. [DOI: 10.1002/lt.500040611] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
36 Cotler S, Gaur L, Gretch D, Wile M, Strong D, Bronner M, Carithers R, Emond M, Perkins J, Nelson K. Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation. Tissue Antigens 1998;52:435-43. [DOI: 10.1111/j.1399-0039.1998.tb03070.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 1.4] [Reference Citation Analysis]
37 Polyak SJ, Morishima C, Shuhart MC, Wang CC, Liu Y, Lee DY. Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin. Gastroenterology. 2007;132:1925-1936. [PMID: 17484885 DOI: 10.1053/j.gastro.2007.02.038] [Cited by in Crossref: 139] [Cited by in F6Publishing: 132] [Article Influence: 9.3] [Reference Citation Analysis]
38 Dusheiko GM. Rolling review-the pathogenesis, diagnosis and management of viral hepatitis. Alimentary Pharmacology & Therapeutics 1994;8:229-53. [DOI: 10.1111/j.1365-2036.1994.tb00283.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
39 Harren P, Rudow D, Teperman L, Dieterich D, Diflo T. Incidence and treatment of recurrent hepatitis C after liver transplantation. Journal of Transplant Coordination 1996;6:24-7. [DOI: 10.7182/prtr.1.6.1.90v76l8661812273] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
40 Terrault NA, Wright TL, Pereira BJ. HEPATITIS C INFECTION IN THE TRANSPLANT RECIPIENT. Infectious Disease Clinics of North America 1995;9:943-64. [DOI: 10.1016/s0891-5520(20)30710-8] [Cited by in Crossref: 11] [Article Influence: 0.4] [Reference Citation Analysis]
41 Shetty S, Adams DH, Hubscher SG. Post-transplant liver biopsy and the immune response: lessons for the clinician. Expert Review of Clinical Immunology 2014;8:645-61. [DOI: 10.1586/eci.12.65] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
42 Gómez-Manero N, Herrero JI, Quiroga J, Sangro B, Pardo F, Cienfuegos JA, Prieto J. Prognostic model for early acute rejection after liver transplantation. Liver Transpl. 2001;7:246-254. [PMID: 11244167 DOI: 10.1053/jlts.2001.22460] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
43 Dousset B, Conti F, Cherruau B, Louvel A, Soubrane O, Houssin D, Calmus Y. Is acute rejection deleterious to long-term allograft function? Journal of Hepatology 1998;29:660-8. [DOI: 10.1016/s0168-8278(98)80163-3] [Cited by in Crossref: 51] [Cited by in F6Publishing: 1] [Article Influence: 2.1] [Reference Citation Analysis]
44 Grassi A, Quarneti C, Ravaioli M, Bianchini F, Susca M, D’Errico A, Piscaglia F, Tamè MR, Andreone P, Grazi G. Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C. Liver Transpl. 2006;12:1673-1681. [PMID: 17031825 DOI: 10.1002/lt.20882] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
45 Berenguer J, Prieto M, Mir J, Cordoba J, Rayón M. Hepatitis C Viral Infection after Orthotopic Liver Transplantation. In: Felipo V, Grisolia S, editors. Hepatic Encephalopathy, Hyperammonemia, and Ammonia Toxicity. Boston: Springer US; 1994. pp. 173-9. [DOI: 10.1007/978-1-4615-1989-8_19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
46 Saab S, Hu R, Ibrahim AB, Goldstein LI, Kunder G, Durazo F, Han S, Yersiz H, Ghobrial RM, Farmer DG. Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C. Am J Transplant. 2003;3:328-333. [PMID: 12614290 DOI: 10.1034/j.1600-6143.2003.00053.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
47 Aardema KL, Nakhleh RE, Terry LK, Burd EM, Ma CK, Moonka DK, Brown KA, Abouljoud MS. Quantitation of hepatitis C virus RNA in liver tissue of allografts: correlation with histologic features and liver function tests. Transplant Proc 1999;31:477-8. [PMID: 10083198 DOI: 10.1016/s0041-1345(98)01716-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Yeh MM, Larson AM, Tung BY, Swanson PE, Upton MP. Endotheliitis in chronic viral hepatitis: a comparison with acute cellular rejection and non-alcoholic steatohepatitis. Am J Surg Pathol 2006;30:727-33. [PMID: 16723850 DOI: 10.1097/00000478-200606000-00008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
49 Targhetta S, Burra P, Popovic A, Silverj E, Pevere S, Russo F, Zanus G, Cecchetto A, Naccarato R, Fagiuoli S. Natural α-IFN in HCV recurrence after liver transplantation. Transplantation Proceedings 2001;33:1457-8. [DOI: 10.1016/s0041-1345(00)02811-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Souza P, Prihoda TJ, Hoyumpa AM, Sharkey FE. Morphologic features resembling transplant rejection in core biopsies of native livers from patients with Hepatitis C. Human Pathology 2009;40:92-7. [DOI: 10.1016/j.humpath.2008.06.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
51 Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayón M, Córdoba J, Herola A, Ascher N, Mir J. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol. 2000;32:673-684. [PMID: 10782918 DOI: 10.1016/s0168-8278(00)80231-7] [Cited by in Crossref: 615] [Cited by in F6Publishing: 93] [Article Influence: 28.0] [Reference Citation Analysis]
52 Pessoa MG, Bzowej N, Berenguer M, Phung Y, Kim M, Ferrell L, Hassoba H, Wright TL. Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation. Hepatology. 1999;30:1513-1520. [PMID: 10573532 DOI: 10.1002/hep.510300610] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 2.8] [Reference Citation Analysis]
53 Rosen HR, Gretch DR, Oehlke M, Flora KD, Benner KG, Rabkin JM, Corless CL. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. Transplantation. 1998;65:1178-1182. [PMID: 9603164 DOI: 10.1097/00007890-199805150-00006] [Cited by in Crossref: 97] [Cited by in F6Publishing: 87] [Article Influence: 4.0] [Reference Citation Analysis]
54 Dienes HP, Drebber U, von Both I. Liver biopsy in hepatitis C. Journal of Hepatology 1999;31:43-6. [DOI: 10.1016/s0168-8278(99)80373-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
55 Asaoka T, Marubashi S, Kobayashi S, Hama N, Eguchi H, Takeda Y, Tanemura M, Wada H, Takemasa I, Takahashi H, Ruiz P, Doki Y, Mori M, Nagano H. Intragraft transcriptome level of CXCL9 as biomarker of acute cellular rejection after liver transplantation. J Surg Res 2012;178:1003-14. [PMID: 22889476 DOI: 10.1016/j.jss.2012.07.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
56 Rodriguez-luna H, Vargas HE. Management of hepatitis C virus infection in the setting of liver transplantation. Liver Transpl 2005;11:479-89. [DOI: 10.1002/lt.20424] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
57 Gholson CF, Mcdonald J, Mcmillan R. Liver transplantation: When is it indicated and what can be expected afterwards? Postgraduate Medicine 2017;97:101-14. [DOI: 10.1080/00325481.1995.11945961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
58 Tamura S, Sugawara Y. Treatment strategy for hepatitis C after liver transplantation. J Hepatobiliary Pancreat Surg 2008;15:111-23. [DOI: 10.1007/s00534-007-1295-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
59 Prakoso E, Tirnitz-parker JEE, Clouston AD, Kayali Z, Lee A, Gan EK, Ramm GA, Kench JG, Bowen DG, Olynyk JK, Mccaughan GW, Shackel NA. Analysis of the intrahepatic ductular reaction and progenitor cell responses in hepatitis C virus recurrence after liver transplantation: DUCTULAR REACTION IN RECURRENT HCV AFTER TRANSPLANTATION. Liver Transpl 2014;20:1508-19. [DOI: 10.1002/lt.24007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
60 Holt CD, Winston DJ. Infections After Liver Transplantation. Transplantation of the Liver. Elsevier; 2005. pp. 963-94. [DOI: 10.1016/b978-0-7216-0118-2.50069-0] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
61 Moll C, Kähler C, Edis C, Nachbauer K, Königsrainer A, Spechtenhauser B, Margreiter R, Vogel W. Early-Level Hepatitis C Viremia After Orthotopic Liver Transplantation Is of Prognostic Significance. Transplantation Proceedings 1998;30:698-700. [DOI: 10.1016/s0041-1345(98)00013-x] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
62 Sánchez-Fueyo A, Restrepo JC, Quintó L, Bruguera M, Grande L, Sánchez-Tapias JM, Rodés J, Rimola A. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft. Transplantation. 2002;73:56-63. [PMID: 11792978 DOI: 10.1097/00007890-200201150-00010] [Cited by in Crossref: 135] [Cited by in F6Publishing: 123] [Article Influence: 6.8] [Reference Citation Analysis]
63 Mack CL, Gonzalez-Peralta RP, Gupta N, Leung D, Narkewicz MR, Roberts EA, Rosenthal P, Schwarz KB;  North American Society for Pediatric Gastroenterology; Hepatology, and Nutrition. NASPGHAN practice guidelines: Diagnosis and management of hepatitis C infection in infants, children, and adolescents. J Pediatr Gastroenterol Nutr. 2012;54:838-855. [PMID: 22487950 DOI: 10.1097/mpg.0b013e318258328d] [Cited by in Crossref: 134] [Cited by in F6Publishing: 46] [Article Influence: 13.4] [Reference Citation Analysis]
64 Féray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynés M, Okamoto H, Bismuth H, Bréchot C. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology. 1995;108:1088-1096. [PMID: 7698576 DOI: 10.1016/0016-5085(95)90207-4] [Cited by in Crossref: 219] [Cited by in F6Publishing: 216] [Article Influence: 8.1] [Reference Citation Analysis]
65 Gaweco AS, Wiesner RH, Porayko M, Rustgi VK, Yong S, Hamdani R, Harig J, Chejfec G, Mcclatchey KD, Van Thiel DH. Intragraft localization of activated nuclear factorκB in recurrent hepatitis C virus disease following liver transplantation. Hepatology 2000;31:1183-91. [DOI: 10.1053/he.2000.6983] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
66 Kelly DA. Current Results and Evolving Indications for Liver Transplantation in Children: . Journal of Pediatric Gastroenterology & Nutrition 1998;27:214-21. [DOI: 10.1097/00005176-199808000-00017] [Cited by in Crossref: 66] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
67 Negro F, Giostra E, Rubbia-brandt L, Mentha G, Colucci G, Morel P, Quadri R, Perrin L, Hadengue A. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation. J Med Virol 1998;56:224-9. [DOI: 10.1002/(sici)1096-9071(199811)56:3<224::aid-jmv8>3.0.co;2-9] [Cited by in Crossref: 14] [Article Influence: 0.6] [Reference Citation Analysis]
68 Alswat KA, Mumtaz K, Jafri W. Liver biopsy for histological assessment: The case in favor. Saudi J Gastroenterol 2010;16:133-9. [PMID: 20339188 DOI: 10.4103/1319-3767.61245] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
69 Bellamy CO, DiMartini AM, Ruppert K, Jain A, Dodson F, Torbenson M, Starzl TE, Fung JJ, Demetris AJ. Liver transplantation for alcoholic cirrhosis: Long term follow-up and impact of disease recurrence. Transplantation. 2001;72:619-626. [PMID: 11544420 DOI: 10.1097/00007890-200108270-00010] [Cited by in Crossref: 133] [Cited by in F6Publishing: 107] [Article Influence: 6.3] [Reference Citation Analysis]
70 Nery J, Esquenazi V, Weppler D, Gomez C, Cirocco R, Gharagozloo H, Zucker K, Casella J, Faria W, Carreno M, Smith J, Markow M, Allouch M, Babischkin S, Bourke G, Miller J, Reddy R, Parker T, Jeffers L, Hill M, Larue S, Schiff E. Hepatitis C in liver transplantation: preliminary study of prognostic factors. Transplant Int 1994;7:229-31. [DOI: 10.1111/j.1432-2277.1994.tb01354.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
71 Wali MH, Heydtmann M, Harrison RF, Gunson BK, Mutimer DJ. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4. Liver Transpl. 2003;9:796-804. [PMID: 12884191 DOI: 10.1053/jlts.2003.50164] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
72 Bizollon T, Ducerf C, Baulieux J, Trepo C. Treatment of recurrent hepatitis C following liver transplantation. Curr Gastroenterol Rep 1999;1:15-9. [DOI: 10.1007/s11894-999-0081-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
73 Ryder SD, Williams R. Liver disease. Postgrad Med J 1994;70:162-84. [PMID: 8183748 DOI: 10.1136/pgmj.70.821.162] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
74 Vierling JM, Villamil FG, Rojter SE, Camacho KB, Goldman DE. Morbidity and mortality of recurrent hepatitis C infection after orthotopic liver transplantation. J Viral Hepat 1997;4:117-24. [DOI: 10.1111/j.1365-2893.1997.tb00172.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
75 Dusheiko GM. New treatments for chronic viral hepatitis B and C. Baillière's Clinical Gastroenterology 1996;10:299-333. [DOI: 10.1016/s0950-3528(96)90009-3] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
76 Belli LS, Silini E, Alberti A, Bellati G, Vai C, Minola E, Rondinara G, de Carlis L, Asti M, Forti D, Ideo G. Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation. Liver Transpl Surg 1996;2:200-5. [PMID: 9346649 DOI: 10.1002/lt.500020305] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
77 Hubscher S. Transplant pathology of the liver. Current Diagnostic Pathology 1994;1:59-69. [DOI: 10.1016/s0968-6053(06)80011-6] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
78 Vandegrift KJ, Critchlow JT, Kapoor A, Friedman DA, Hudson PJ. Peromyscus as a model system for human hepatitis C: An opportunity to advance our understanding of a complex host parasite system. Semin Cell Dev Biol 2017;61:123-30. [PMID: 27498234 DOI: 10.1016/j.semcdb.2016.07.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
79 Lipson K, Lappalainen M, Hockerstedt K, Lautenschlager I. Post-transplant reactivation of hepatitis C virus: lymphocyte infiltration and the expression of adhesion molecules and their ligands in liver allografts. Apmis 2006;114:247-54. [DOI: 10.1111/j.1600-0463.2006.apm_130.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
80 Theise ND, Bodenheimer HC, Ferrell LD. Acute and chronic viral hepatitis. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 361-401. [DOI: 10.1016/b978-0-7020-3398-8.00007-6] [Cited by in Crossref: 6] [Article Influence: 0.6] [Reference Citation Analysis]
81 Saab S. Is it cost-effective to treat recurrent hepatitis C infection in orthotopic liver transplantation patients? Liver Transplantation 2002;8:449-57. [DOI: 10.1053/jlts.2002.32717] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
82 Johnson K, Kotiesh A, Boitnott JK, Torbenson M. Histology of symptomatic acute hepatitis C infection in immunocompetent adults. Am J Surg Pathol 2007;31:1754-8. [PMID: 18059233 DOI: 10.1097/PAS.0b013e318093f90e] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
83 Alter HJ, Sanchez-pescador R, Urdea MS, Wilber JC, Lagier RJ, Bisceglie AM, Shih JW, Neuwald PD. Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA. J Viral Hepat 1995;2:121-32. [DOI: 10.1111/j.1365-2893.1995.tb00017.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 2.8] [Reference Citation Analysis]
84 Scheuer PJ, Krawczynski K, Dhillon AP. Histopathology and detection of hepatitis C virus in liver. Springer Semin Immunopathol 1997;19:27-45. [DOI: 10.1007/bf00945023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
85 Polyak SJ. Hepatitis C virus–cell interactions and their role in pathogenesis. Clinics in Liver Disease 2003;7:67-88. [DOI: 10.1016/s1089-3261(02)00075-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
86 Vyberg M. The hepatitis-associated bile duct lesion. Liver 1993;13:289-301. [DOI: 10.1111/j.1600-0676.1993.tb00648.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
87 Cotler SJ, Ganger DR, Kaur S, Rosenblate H, Jakate S, Sullivan DG, Ng KW, Gretch DR, Jensen DM. Daily interferon therapy for hepatitis C virus infection in liver transplant recipients. Transplantation. 2001;71:261-266. [PMID: 11213071 DOI: 10.1097/00007890-200101270-00017] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
88 Charco R, Vargas V, Allende H, Edo A, Balsells J, Murio E, Lázaro JL, Bilbao J, Margarit C. Is hepatitis C virus recurrence a risk factor for chronic liver allograft rejection? Transplant Int 1996;9:S195-7. [DOI: 10.1111/j.1432-2277.1996.tb01606.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
89 Kumar KS, Saboorian MH, Lee WM. Cholestatic presentation of chronic hepatitis C: a clinical and histological study with a review of the literature. Dig Dis Sci 2001;46:2066-73. [PMID: 11680577 DOI: 10.1023/a:1011925907102] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
90 McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation. Liver Transpl. 2004;10:975-985. [PMID: 15390322 DOI: 10.1002/lt.20213] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
91 Demetris A, Nalesnik M, Randhawa P, Wu T, Minervini M, Lai C, Lu Z. Histological Patterns of Rejection and Other Causes of Liver Dysfunction. Transplantation of the Liver. Elsevier; 2005. pp. 1057-128. [DOI: 10.1016/b978-0-7216-0118-2.50074-4] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
92 Zeldis JB, Jensen P. Hepatitis C virus pathogenicity: The corner pieces of the jigsaw puzzle are found. Gastroenterology 1994;106:1119-20. [DOI: 10.1016/0016-5085(94)90776-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
93 Gretch DR, Bacchi CE, Corey L, dela Rosa C, Lesniewski RR, Kowdley K, Gown A, Frank I, Perkins JD, Carithers RL. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology. 1995;22:1-9. [PMID: 7601397 DOI: 10.1002/hep.1840220102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
94 Johnson RJ, Willson R, Yamabe H, Couser W, Alpers CE, Wener MH, Davis C, Gretch DR. Renal manifestations of hepatitis C virus infection. Kidney Int 1994;46:1255-63. [PMID: 7853784 DOI: 10.1038/ki.1994.393] [Cited by in Crossref: 101] [Cited by in F6Publishing: 86] [Article Influence: 3.7] [Reference Citation Analysis]
95 Abraczinskas D, Chung R. Allograft dysfunction and hyperbilirubinemia in a liver transplant recipient: Liver transplant. Transplant Infectious Disease 2000;2:186-93. [DOI: 10.1034/j.1399-3062.2000.020404.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
96 Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology 1994;20:S24-7. [DOI: 10.1002/hep.1840200708] [Cited by in Crossref: 94] [Cited by in F6Publishing: 79] [Article Influence: 3.4] [Reference Citation Analysis]
97 Saxena R, Crawford JM, Navarro VJ, Friedman AL, Robert ME. Utilization of acidophil bodies in the diagnosis of recurrent hepatitis C infection after orthotopic liver transplantation. Mod Pathol 2002;15:897-903. [PMID: 12218206 DOI: 10.1038/modpathol.3880626] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
98 Sánchez-fueyo A, Giménez-barcons M, Puig-basagoiti F, Rimola A, María Sánchez-tapias J, Sáiz JC, Rodés J. Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation: HCV Quasispecies After Liver Transplantation. J Med Virol 2001;65:266-75. [DOI: 10.1002/jmv.2029] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
99 Belli LS, Zavaglia C, Alberti AB, Poli F, Rondinara G, Silini E, Taioli E, de Carlis L, Scalamogna M, Forti D, Pinzello G, Idèo G. Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation: Influence of Immunogenetic Background on the Outcome of Recurrent Hepatitis C After Liver Transplantation. Hepatology 2000;31:1345-50. [DOI: 10.1053/jhep.2000.7879] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
100 Singh N, Gayowski T, Wannstedt CF, Shakil AO, Wagener MM, Fung JJ, Marino IR. Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial. Transplantation. 1998;65:82-86. [PMID: 9448149 DOI: 10.1097/00007890-199801150-00016] [Cited by in Crossref: 132] [Cited by in F6Publishing: 114] [Article Influence: 5.5] [Reference Citation Analysis]
101 Barcena R, Del Campo S, Sanroman A, Nuño J, Zelaya R, Honrubia A, Vicente E, Monge G. Prospective study of hepatitis C virus infection after orthotopic liver transplantation. Transplantation Proceedings 1997;29:515-6. [DOI: 10.1016/s0041-1345(96)00245-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
102 Regev A, Molina E, Moura R, Bejarano PA, Khaled A, Ruiz P, Arheart K, Berho M, Drachenberg CB, Mendez P. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation. Liver Transpl. 2004;10:1233-1239. [PMID: 15376303 DOI: 10.1002/lt.20245] [Cited by in Crossref: 102] [Cited by in F6Publishing: 84] [Article Influence: 6.0] [Reference Citation Analysis]
103 Doria C, di Francesco F, Marino IR, Ramirez CB, Frank A, Iaria M, Galati SA, Farber JL. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts. Transplant Proc 2006;38:3597-600. [PMID: 17175342 DOI: 10.1016/j.transproceed.2006.10.175] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
104 Khabar KS, Polyak SJ. Hepatitis C virus-host interactions: the NS5A protein and the interferon/chemokine systems. J Interferon Cytokine Res 2002;22:1005-12. [PMID: 12433279 DOI: 10.1089/107999002760624224] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
105 Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, Roberts J, Wilber J, Sheridan P, Urdea M. Interferon-α therapy for hepatitis c virus infection after liver transplantation. Hepatology 1994;20:773-9. [DOI: 10.1002/hep.1840200402] [Cited by in Crossref: 140] [Cited by in F6Publishing: 119] [Article Influence: 5.0] [Reference Citation Analysis]
106 Féray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Urdea M, Reynes M, Bréchot C, Bismuth H. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994;20:1137-43. [PMID: 7927244 DOI: 10.1002/hep.1840200506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 23] [Article Influence: 0.2] [Reference Citation Analysis]
107 Gane E. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients. Liver Transpl. 2003;9:S28-S34. [PMID: 14586892 DOI: 10.1053/jlts.2003.50248] [Cited by in Crossref: 170] [Cited by in F6Publishing: 153] [Article Influence: 9.4] [Reference Citation Analysis]
108 Berenguer M, Prieto M, Córdoba J, Rayón JM, Carrasco D, Olaso V, San-juan F, Gobernado M, Mir J, Berenguer J. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. Journal of Hepatology 1998;28:756-63. [DOI: 10.1016/s0168-8278(98)80224-9] [Cited by in Crossref: 140] [Cited by in F6Publishing: 9] [Article Influence: 5.8] [Reference Citation Analysis]
109 Safadi R, Shouval D, Ashur Y, Eid A, Jurim O, Livni N, Galun E. Natural course of HCV viremia following liver transplantation and clinical course of reinfection. Transplant Proc 1997;29:2635-9. [PMID: 9290771 DOI: 10.1016/s0041-1345(97)00537-x] [Reference Citation Analysis]
110 Longerich T, Schirmacher P. General aspects and pitfalls in liver transplant pathology. Clin Transplant 2006;20 Suppl 17:60-8. [PMID: 17100703 DOI: 10.1111/j.1399-0012.2006.00602.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
111 Harrison RF, Davies MH, Neuberger JM, Hubscher SG. Fibrous and obliterative cholangitis in liver allografts: Evidence of recurrent primary sclerosing cholangitis? Hepatology 1994;20:356-61. [DOI: 10.1002/hep.1840200214] [Cited by in Crossref: 98] [Cited by in F6Publishing: 73] [Article Influence: 3.5] [Reference Citation Analysis]
112 Safadi R, Shouval D, Kaspa RT, Ashur Y, Ilan Y. Beneficial effect of ribavirin on hepatitis C-associated cryoglobulinemia after liver transplantation. Liver Transpl 1996;2:263-8. [DOI: 10.1002/lt.500020403] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
113 Jain A, Demetris AJ, Manez R, Tsamanadas AC, Van Thiel D, Rakela J, Starzl TE, Fung JJ. Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon. Liver Transpl 1998;4:197-203. [DOI: 10.1002/lt.500040315] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
114 Rigamonti C, Vidali M, Donato MF, Sutti S, Occhino G, Ivaldi A, Arosio E, Agnelli F, Rossi G, Colombo M, Albano E. Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C. Am J Transplant 2009;9:601-9. [PMID: 19191768 DOI: 10.1111/j.1600-6143.2008.02520.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
115 Vargas V, Comas P, Castells L, Quer J, Esteban J, Allende E, Esteban R, Guardia J, Margarit C. Incidence and outcome of hepatitis C virus infection after liver transplantation. Transplant Int 1994;7:216-20. [DOI: 10.1111/j.1432-2277.1994.tb01350.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
116 Haugk B, El-refaie A, Burt AD. Pathology of liver transplantation. Current Diagnostic Pathology 2007;13:75-84. [DOI: 10.1016/j.cdip.2006.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
117 Wright TL, Pereira B. Liver transplantation for chronic viral hepatitis. Liver Transpl 1995;1:30-42. [DOI: 10.1002/lt.500010108] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
118 Rosen HR, Martin P. Viral hepatitis in the liver transplant recipient. Infect Dis Clin North Am 2000;14:761-84. [PMID: 10987119 DOI: 10.1016/s0891-5520(05)70130-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
119 Caccamo L, Gridelli B, Sampietro M, Melada E, Doglia M, Lunghi G, Corbetta N, Rossi G, Colledan M, Fassati LR, Fiorelli G, Galmarini D. Hepatitis C virus Genotypes and reinfection of the graft during long-term follow-up in 35 liver transplant recipients. Transplant Int 1996;9:S204-9. [DOI: 10.1111/j.1432-2277.1996.tb01610.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
120 Ahmed A, Keeffe EB. Hepatitis C virus and liver transplantation. Clin Liver Dis. 2001;5:1073-1090. [PMID: 11685796 DOI: 10.1016/s1089-3261(05)70210-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
121 Berenguer M, Wright TL. Hepatitis C and liver transplantation. Gut. 1999;45:159-163. [PMID: 10403720 DOI: 10.1136/gut.45.2.159] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 1.1] [Reference Citation Analysis]
122 Jothimani D, Govil S, Rela M. Management of post liver transplantation recurrent hepatitis C infection with directly acting antiviral drugs: a review. Hepatol Int 2016;10:749-61. [PMID: 27337961 DOI: 10.1007/s12072-016-9744-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
123 Barnes EJ, Abdel-rehim MM, Goulis Y, Ragab MA, Davies S, Dhillon A, Davidson B, Rolles K, Burroughs A. Applications and Limitations of Blood Eosinophilia for the Diagnosis of Acute Cellular Rejection in Liver Transplantation: Applications and Limitations of Blood Eosinophilia. American Journal of Transplantation 2003;3:432-8. [DOI: 10.1034/j.1600-6143.2003.00083.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
124 Safadi R, Shouval D, E'id A, Ilan Y, Tur-kaspa R, Jurim O. Hepatitis-C-associated cryoglobulinemia after liver transplantation. Transplantation Proceedings 1997;29:2684-6. [DOI: 10.1016/s0041-1345(97)00555-1] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
125 Alberti A, Belli L, Silini E, Zavaglia C, Iamoni G, Rondinara G, De Carlis L, Forti D, Ideo G. Hepatitis C virus genotypes and severe hepatitis C virus recurrence after liver transplantation. Transplantation Proceedings 1997;29:522-3. [DOI: 10.1016/s0041-1345(96)00249-7] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
126 Pessoa MG, Wright TL. HEPATITIS C INFECTION IN TRANSPLANTATION. Clinics in Liver Disease 1997;1:663-90. [DOI: 10.1016/s1089-3261(05)70328-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
127 Herrero JI, Peña AD, Quiroga J, Sangro B, Garcia N, Sola I, Cienfuegos JA, Civeira MP, Prieto J. Risk factors for recurrence of hepatitis C after liver transplantation. Liver Transpl 1998;4:265-70. [DOI: 10.1002/lt.500040406] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
128 Grassi A, Ballardini G. Post-liver transplant hepatitis C virus recurrence: An unresolved thorny problem. World J Gastroenterol 2014; 20(32): 11095-11115 [PMID: 25170198 DOI: 10.3748/wjg.v20.i32.11095] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
129 Tchervenkov JI, Tector AJ, Barkun JS, Sherker A, Forbes CD, Elias N, Cantarovich M, Cleland P, Metrakos P, Meakins JL. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant. Ann Surg 1997;226:356-65; discussion 365-8. [PMID: 9339942 DOI: 10.1097/00000658-199709000-00015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 1.4] [Reference Citation Analysis]
130 Charco R, Murio E, Edo A, Balsclls J, Lazaro JL, Bilbao I, Hidalgo E, Margarit C. Early use of tacrolimus as rescue therapy for refractory liver allograft rejection. Transplant Int 1998;11:S313-7. [DOI: 10.1111/j.1432-2277.1998.tb01142.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
131 Shiffman ML, Hofmann CM, Luketic VA, Sanyal AJ. Use of granulocyte macrophage colony stimulating factor alone or in combination with interferon-alpha-2b for treatment of chronic hepatitis C. J Hepatol 1998;28:382-9. [PMID: 9551674 DOI: 10.1016/s0168-8278(98)80310-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
132 Ziarkiewicz-wróblewska B, Górnicka B, Ołdakowska-jedynak U, Bogdańska M, Wróblewski T, Morton M, Ziółkowski J, Pączek L, Krawczyk M, Wasiutyński A. Morphologic Features of Hepatitis C Recurrence in Patients After Orthotopic Liver Transplantation-Preliminary Analysis of our Case Observations. Transplantation Proceedings 2006;38:226-30. [DOI: 10.1016/j.transproceed.2005.12.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
133 Marzano A, Smedile A, Abate M, Ottobrelli A, Brunetto M, Negro F, Farci P, Durazzo M, David E, Lagget M, Verme G, Bonino F, Rizzetto M. Hepatitis type C after ortothopic liver transplantation: reinfection and disease recurrence. Journal of Hepatology 1994;21:961-5. [DOI: 10.1016/s0168-8278(05)80602-6] [Cited by in Crossref: 21] [Article Influence: 0.8] [Reference Citation Analysis]
134 Colantoni A, De Maria N, Fagiuoli S, Van Thiel DH. Liver transplantation in virus-induced chronic liver disease. Baillière's Clinical Gastroenterology 1996;10:375-88. [DOI: 10.1016/s0950-3528(96)90011-1] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
135 Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology. 2002;122:889-896. [PMID: 11910340 DOI: 10.1053/gast.2002.32418] [Cited by in Crossref: 871] [Cited by in F6Publishing: 766] [Article Influence: 43.6] [Reference Citation Analysis]
136 Caccamo L, Rossi G, Reggiani P, Gatti S, Maggi U, Paone G, Fassati L. Liver transplantation for viral hepatitis-associated cirrhosis. Transplantation Proceedings 1998;30:2107-11. [DOI: 10.1016/s0041-1345(98)00555-7] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
137 Weisiger RA. Impact of Extracellular and Intracellular Diffusion on Hepatic Uptake Kinetics. In: Bassingthwaighte JB, Linehan JH, Goresky CA, editors. Whole Organ Approaches to Cellular Metabolism. New York: Springer; 1998. pp. 389-423. [DOI: 10.1007/978-1-4612-2184-5_16] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
138 Theise ND, Bodenheimer HC, Guido M. Viral Hepatitis. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 372-415. [DOI: 10.1016/b978-0-7020-6697-9.00006-6] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
139 Kallwitz ER, Cotler SJ. Care of the Liver Transplant Patient. Disease-a-Month 2008;54:486-507. [DOI: 10.1016/j.disamonth.2008.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
140 Asaoka T, Kato T, Marubashi S, Dono K, Hama N, Takahashi H, Kobayashi S, Takeda Y, Takemasa I, Nagano H. Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation. Liver Transpl. 2009;15:1738-1749. [PMID: 19938108 DOI: 10.1002/lt.21883] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
141 Wieczorek A, Stępień PM, Zarębska-Michaluk D, Kryczka W, Pabjan P, Król T. Megamitochondria formation in hepatocytes of patient with chronic hepatitis C - a case report. Clin Exp Hepatol 2017;3:169-75. [PMID: 29062908 DOI: 10.5114/ceh.2017.68287] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
142 Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, Ascher NL, Neuwald P, Wilber J, Urdea M, Quan S, Sanchez-pescador R, Wright TL. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994;106:994-9. [DOI: 10.1016/0016-5085(94)90759-5] [Cited by in Crossref: 233] [Cited by in F6Publishing: 220] [Article Influence: 8.3] [Reference Citation Analysis]
143 Kendrick EA, McVicar JP, Kowdley KV, Bronner MP, Emond MJ, Alpers CE, Gretch DR, Carithers RL, Perkins JD, Davis CL. Renal disease in hepatitis C-positive liver transplant recipients. Transplantation. 1997;63:1287-1293. [PMID: 9158023 DOI: 10.1097/00007890-199705150-00016] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 1.7] [Reference Citation Analysis]
144 Rothstein KD, Munoz SJ. Interferon and Other Therapies for Hepatitis B and Hepatitis C Infections. Clinics in Laboratory Medicine 1996;16:465-91. [DOI: 10.1016/s0272-2712(18)30280-4] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
145 Caccamo L, Gridelli B, Sampietro M, Melada E, Doglia M, Lunghi G, Corbetta N, Rossi G, Colledan M, Fassati LR, Fiorelli G, Galmarini D. Hepatitis C virus genotypes and reinfection of the graft during long-term follow-up in 35 liver transplant recipients. Transpl Int 1996;9 Suppl 1:S204-9. [PMID: 8959828 DOI: 10.1007/978-3-662-00818-8_52] [Reference Citation Analysis]
146 Chazouilleres O, Wright TL. Hepatitis C and liver transplantation. J Gastroenterol Hepatol 1995;10:471-80. [PMID: 8527717 DOI: 10.1111/j.1440-1746.1995.tb01603.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
147 Knoop M, Lüsebrink R, Langrehr J, König V, Berg T, Wedell A, Hopf U, Neuhaus P. Incidence and clinical relevance of recurrent hepatitis C infection after orthotopic liver transplantation. Transplant Int 1994;7:221-3. [DOI: 10.1111/j.1432-2277.1994.tb01351.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
148 Lim HL, Lau GK, Davis GL, Dolson DJ, Lau JY. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 1994;106:248-51. [DOI: 10.1016/s0016-5085(94)95829-7] [Cited by in Crossref: 114] [Cited by in F6Publishing: 5] [Article Influence: 4.1] [Reference Citation Analysis]
149 Khettry U, Robiou C, Jenkins RL, Loda M, Lewis WD. Recurrent Hepatitis C in Liver Allografts: Early Histologic Indicators. Int J Surg Pathol 1998;6:197-204. [DOI: 10.1177/106689699800600403] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
150 Arista-Nasr J, Pichardo-Bahena R, Castañeda B, Lisker M, Keirns C. Hepatitis C: a disease with a wide morphological spectrum? J Clin Gastroenterol 1996;22:121-5. [PMID: 8742651 DOI: 10.1097/00004836-199603000-00010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
151 Bizollon T, Ducerf C, Trepo C, Mutimer D. Hepatitis C virus recurrence after liver transplantation. Gut 1999;44:575-8. [PMID: 10075968 DOI: 10.1136/gut.44.4.575] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 1.9] [Reference Citation Analysis]
152 Hui C, Lau E, Monto A, Kim M, Luk JM, Poon RTP, Leung N, Lo C, Fan S, Lau GKK, Wright TL. Natural History of Patients with Recurrent Chronic Hepatitis C Virus and Occult Hepatitis B Co-Infection after Liver Transplantation.: In 118 patients with viral and histologic evidence of recurrent hepatitis C infection coinfected with occult hepatitis B virus after liver transplantation, the occult hepatitis B virus coinfection was not associated with accelerated fibrosis. Am J Transplant 2006;6:1600-8. [DOI: 10.1111/j.1600-6143.2006.01370.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
153 Schirren CA, Jung M, Worzfeld T, Mamin M, Baretton GB, Gruener NH, Gerlach JT, Diepolder HM, Zachoval R, Pape GR. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection. Liver Transpl 2000;6:222-8. [DOI: 10.1002/lt.500060204] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
154 Ong JP, Barnes DS, Younossi ZM, Gramlich T, Yen-lieberman B, Goormastic M, Sheffield C, Hoercher K, Starling R, Young J, Smedira N, Mccarthy P. Outcome ofDe Novohepatitis C virus infection in heart transplant recipients. Hepatology 1999;30:1293-8. [DOI: 10.1002/hep.510300519] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 2.8] [Reference Citation Analysis]
155 Di Bisceglie AM. Liver transplantation for hepatitis C: The promise and the challenge. Hepatology 1995;22:660-2. [DOI: 10.1002/hep.1840220241] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
156 Collier J, Heathcote J. Hepatitis C viral infection in the immunosuppressed patient. Hepatology 1998;27:2-6. [DOI: 10.1002/hep.510270102] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
157 Demetris A, Crawford JM, Minervini MI, Nalesnik M, Ochoa E, Randhawa P, Sasatomi E, Wu T. Transplantation Pathology of the Liver. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Elsevier; 2009. pp. 1169-229. [DOI: 10.1016/b978-141604059-0.50047-3] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]